Insider trading

Period: 120 months Stock: XFOR Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

45 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

45 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

45 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

45 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
45 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
45 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

45 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Aug 2026
Craig Adam R Executive Chairman
Sold at will
$210.83K 47,436 at 4.44
12.6%
Not planned
12 Aug 2026
Volpone John President
Sold at will
$109.23K 24,576 at 4.44
8.5%
Not planned
23 Oct 2025
Craig Adam R Executive Chairman
Bought
$250.00K 86,206 at 2.90
29.7%
First buy on file
16 May 2025
Baldry Mark Chief Commercial Officer
Bought
$2.56K 1,032 at 2.48
4.2%
24 Jan 2025
Baldry Mark Chief Commercial Officer
Sold at will
$13.24K 29,159 at 0.45
23.7%
Not planned
24 Jan 2025
DiBiase Mary Chief Operating Officer
Sold at will
$10.09K 22,258 at 0.45
4.3%
Not planned
24 Jan 2025
Arbet-Engels Christophe Chief Medical Officer
Sold at will
$5.28K 11,624 at 0.45
45.0%
Not planned
15 Nov 2024
Baldry Mark Chief Commercial Officer
Bought
$4.60K 13,404 at 0.34
11.6%
7 Oct 2024
Taveras Arthur Chief Scientific Officer
Sold at will
$43.31K 76,920 at 0.56
16.5%
Not planned
7 Oct 2024
DiBiase Mary Chief Operating Officer
Sold at will
$38.33K 67,695 at 0.57
13.0%
Not planned
7 Oct 2024
Baldry Mark Chief Commercial Officer
Sold at will
$6.51K 11,127 at 0.58
18.7%
Not planned
9 Sep 2024
DiBiase Mary Chief Operating Officer
Sold at will
$1.74K 2,642 at 0.66
0.9%
Not planned
17 May 2024
Baldry Mark Chief Commercial Officer
Bought
$14.65K 21,646 at 0.68
23.0%
First buy on file
11 Mar 2024
DiBiase Mary Chief Operating Officer
Sold at will
$13.59K 15,409 at 0.88
5.0%
Not planned
11 Mar 2024
Taveras Arthur Chief Scientific Officer
Sold at will
$12.55K 14,235 at 0.88
5.7%
Not planned
12 Feb 2024
DiBiase Mary Chief Operating Officer
Sold at will
$3.71K 3,683 at 1.01
1.2%
Not planned
12 Feb 2024
Taveras Arthur Chief Scientific Officer
Sold at will
$792.67 787 at 1.01
0.3%
Not planned
1 Nov 2023
Taveras Arthur Chief Scientific Officer
Sold on a plan
$49.42K 67,695 at 0.73
21.4%
Planned (10b5-1)
1 Nov 2023
DiBiase Mary Chief Operating Officer
Sold on a plan
$49.42K 67,695 at 0.73
17.9%
Planned (10b5-1)
1 Nov 2023
Baldry Mark Chief Commercial Officer
Sold on a plan
$7.49K 10,257 at 0.73
29.4%
Planned (10b5-1)
8 Sep 2023
DiBiase Mary Chief Operating Officer
Sold at will
$3.30K 2,642 at 1.25
1.8%
Not planned
10 Aug 2023
Stewart Murray Interim Chief Medical Officer
Sold at will
$137.86K 130,056 at 1.06
47.0%
Not planned
30 Jun 2023
DiBiase Mary Chief Operating Officer
Sold at will
$876.96 464 at 1.89
0.3%
Not planned
23 Jun 2023
DiBiase Mary Chief Operating Officer
Sold at will
$1.65K 857 at 1.93
0.6%
Not planned
15 Jun 2023
DiBiase Mary Chief Operating Officer
Sold at will
$1.91K 857 at 2.23
0.6%
Not planned
10 Mar 2023
DiBiase Mary Chief Operating Officer
Sold, plan not stated
$15.28K 18,192 at 0.84
10.6%
10 Mar 2023
Taveras Arthur Chief Scientific Officer
Sold, plan not stated
$14.12K 16,806 at 0.84
16.3%
13 Feb 2023
DiBiase Mary Chief Operating Officer
Sold, plan not stated
$4.04K 4,348 at 0.93
2.5%
13 Feb 2023
Taveras Arthur Chief Scientific Officer
Sold, plan not stated
$863.04 928 at 0.93
0.9%
17 Aug 2022
DiBiase Mary Chief Operating Officer
Sold, plan not stated
no price 1,713 shares
1.0%
17 Aug 2022
Meisner Derek M Chief Legal Officer
Sold, plan not stated
no price 8,334 shares
5.4%
30 Jun 2022
DiBiase Mary Chief Operating Officer
Sold, plan not stated
no price 1,578 shares
0.9%
24 Jun 2022
DiBiase Mary Chief Operating Officer
Sold, plan not stated
no price 856 shares
0.5%
24 Jun 2022
Meisner Derek M Chief Legal Officer
Sold, plan not stated
no price 4,166 shares
2.6%
16 Jun 2022
Meisner Derek M Chief Legal Officer
Sold, plan not stated
no price 4,166 shares
2.6%
16 Jun 2022
DiBiase Mary Chief Operating Officer
Sold, plan not stated
no price 856 shares
0.5%
11 Feb 2022
Cadavid Diego Chief Medical Officer
Sold, plan not stated
no price 928 shares
11.5%
11 Feb 2022
DiBiase Mary Chief Operating Officer
Sold, plan not stated
no price 12,545 shares
13.9%
11 Feb 2022
Meisner Derek M Chief Legal Officer
Sold, plan not stated
no price 15,909 shares
21.9%
17 Aug 2021
Meisner Derek M General Counsel
Sold, plan not stated
$42.49K 8,332 at 5.10
10.3%
24 Jun 2021
Meisner Derek M General Counsel
Sold, plan not stated
$29.16K 4,166 at 7.00
4.9%
15 Jun 2021
Meisner Derek M General Counsel
Sold, plan not stated
$32.66K 4,166 at 7.84
5.4%
9 Sep 2020
Meisner Derek M General Counsel
Sold, plan not stated
$67.09K 8,334 at 8.05
33.3%
9 Sep 2020
Skerlj Renato Chief Scientific Officer
Sold, plan not stated
$46.96K 5,834 at 8.05
12.2%
30 Jun 2020
Mostafa Adam S. See Remarks
Sold, plan not stated
$15.59K 1,725 at 9.04
16.3%
Showing 1–45 of 45.